Nachrichten zur CATALENT Aktie

Novo Holdings completes $16.5 bln takeover of Catalent

Novo Holdings has completed its $16.5 billion takeover of Catalent , the contract drug manufacturer announced on Wednesday, days after…

Novo Holdings completes $16.5 billion takeover of Catalent By Reuters

Novo Holdings completes $16.5 billion takeover of Catalent…

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S’s…

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

Bagsværd, Denmark, 6 December 2024 — Today, the European Commission approved Novo Holdings A/S’ acquisition of Catalent, Inc. (Catalent), a global…

Novo Holdings $16.5 billion Catalent buy wins EU antitrust approval By Reuters

Novo Holdings $16.5 billion Catalent buy wins EU antitrust approval…

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal By Reuters

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal…

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings By Reuters

Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings…

Catalent reports Q1 loss, misses market expectations By Investing.com

Catalent reports Q1 loss, misses market expectations…

Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates

Catalent (CTLT) delivered earnings and revenue surprises of -218.18% and 5.28%, respectively, for the quarter ended September 2024. Do the…

Roche comes out against clearing takeover of drug manufacturer Catalent By Reuters

Roche comes out against clearing takeover of drug manufacturer Catalent…

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings buyout By Reuters

Catalent CEO to remain in charge of contract drugmaker after Novo Holdings buyout…

Catalent to sell New Jersey facility By Reuters

Catalent to sell New Jersey facility…

Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent

Ardena acquires Catalents Somerset, NJ facility, expanding its US presence and boosting advanced oral drug product manufacturing capabilities.…

Catalent delays filing of annual report By Reuters

Catalent delays filing of annual report…

Catalent beats revenue estimates ahead of deal close with Novo Nordisk parent By Reuters

Catalent beats revenue estimates ahead of deal close with Novo Nordisk parent…

CDMO executive says Novo purchase of Catalent may help competition - CTFN

…

Catalent (CTLT) Expands Its Facility Capabilities in Germany

Catalents (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical…

Global Dermal Toxicity Testing Market Size To Exceed USD 4.95 Billion By 2033 | CAGR of 8.11%

The Global Dermal Toxicity Testing Market Size was Valued at USD 2.27 Billion in 2023 and the Worldwide Dermal Toxicity…

Catalent exec sells over $76k in company stock By Investing.com

Catalent exec sells over $76k in company stock…

Catalents (CTLT) Latest Partnership to Boost Clinical Trials

Catalents (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving…

Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up

Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.…

Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings

Robbins LLP is investigating the acquisition of Catalent, Inc. (CTLT) by Novo Holdings to determine if it is in the…

Ares, Blue Owl Lead $4.8 Billion Private Debt for Catalent Deal

Ares Management Corp. and Blue Owl Capital Inc. are leading a group of private credit lenders providing $4.8 billion of…

Catalent executive sells $21,749 in company stock By Investing.com

Catalent executive sells $21,749 in company stock…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Catalent (CTLT) Q2 Earnings Lag Estimates, Gross Margin Down

Catalent (CTLT) reports lower revenues in Biologics segments in its second-quarter fiscal 2024, resulting in overall soft performance.…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

Novo Nordisk acquisition of Catalent production sensible, analysts say

Novo Nordisk (NYSE:NVO)’s takeover of three production sites through the acquisition of Catalent Inc (NYSE:CTLT) is a sensible move, analysts…

Novo Nordisk acquisition of Catalent production sensible, analysts say

Novo Nordisk (NYSE:NVO)’s takeover of three production sites through the acquisition of Catalent Inc (NYSE:CTLT) is a sensible move, analysts…

Catalent downgraded post Novo Nordisk acquisition deal By Investing.com

Catalent downgraded post Novo Nordisk acquisition deal…

Gummy Market to surpass $51 Bn by 2032, Says Global Market Insights Inc.

Major gummy market participants include Nestle SA, Bayer AG, Church & Dwight Co. Inc, Procter & Gamble, Unilever PLC (OLLY),…

Strength Seen in Catalent (CTLT): Can Its 9.7% Jump Turn into More Strength?

Catalent (CTLT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Catalent acquisition by Novo Nordisk ‘a positive’

Catalent acquisition by Novo Nordisk ‘a positive’ - JPMorgan…

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Catalent, Inc. (NYSE – CTLT), Everbridge, Inc. (Nasdaq – EVBG), Slam Corp. (Nasdaq – SLAM), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

BALA CYNWYD, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.…

dpa-AFX ProFeed